ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanza, L. A.
Right arrow Articles by Putnam, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanza, L. A.
Right arrow Articles by Putnam, J. B., Jr

The Annals of Thoracic Surgery, Vol 54, 244-247, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Long-term survival after resection of pulmonary metastases from carcinoma of the breast

LA Lanza, G Natarajan, JA Roth and JB Putnam Jr
Department of Thoracic Surgery, University of Texas MD Anderson Cancer Center, Houston 77030-4009.

Resection of isolated pulmonary metastases may yield improved survival in select patients. Between 1981 and 1991, 44 women (median age, 55 years) with a history of breast cancer underwent 47 thoracotomies with no operative deaths and only three minor postoperative complications (3/47, 6.4%). Confirmation of the metastatic origin of the lung lesion was made by direct histological comparison with the primary. Three patients had benign nodules and were excluded, and 4 patients had less than complete resection at thoracotomy. The median survival after thoracotomy of the remaining 37 patients with completely resected metastases was 47 +/- 5.5 months, and their actuarial 5-year survival was 49.5%. Patients with a disease-free interval of longer than 12 months had a longer survival (median survival, 82 +/- 6 months; 5-year survival, 57%) than patients with a disease-free interval of 12 months or less (median survival, 15 +/- 3.6 months; 5-year survival, 0%) (p = 0.004). Patients with estrogen receptor-positive status (n = 14) tended to have longer survival after resection than patients with estrogen receptor-negative status (n = 15) (median survival, 81 +/- 9 months versus 23 +/- 6 months, respectively; p = 0.098). Other clinical variables analyzed did not predict survival after thoracotomy. We conclude that resection of pulmonary metastases in patients with breast cancer can be done safely and may result in long-term survival for a substantial number of patients. Patients with a disease-free interval of longer than 12 months have an excellent prognosis after complete resection.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Welter, J. Jacobs, T. Krbek, M. Totsch, and G. Stamatis
Pulmonary metastases of breast cancer. When is resection indicated?
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1228 - 1234.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. J. Gradishar, J. R. Bellon, M. A. Gadd, H. A. D'Alessandro, and K. Braaten
Case 30-2008 -- A 47-Year-Old Woman with a Mass in the Breast and a Solitary Lesion in the Spine
N. Engl. J. Med., September 25, 2008; 359(13): 1382 - 1391.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. V. Babiera, R. Rao, L. Feng, F. Meric-Bernstam, H. M. Kuerer, S. E. Singletary, K. K. Hunt, M. I. Ross, K. M. Gwyn, B. W. Feig, et al.
Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor
Ann. Surg. Oncol., June 1, 2006; 13(6): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Tanaka, M. Li, N. Hanaoka, T. Bando, T. Fukuse, S. Hasegawa, and H. Wada
Surgery for Pulmonary Nodules in Breast Cancer Patients
Ann. Thorac. Surg., May 1, 2005; 79(5): 1711 - 1714.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. E. Singletary, G. Walsh, J.-N. Vauthey, S. Curley, R. Sawaya, K. L. Weber, F. Meric, and G. N. Hortobagyi
A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer
Oncologist, June 1, 2003; 8(3): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Friedel, U. Pastorino, R. J. Ginsberg, P. Goldstraw, M. Johnston, H. Pass, J. B. Putnam, and H. Toomes
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases
Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. J. Landreneau, T. De Giacomo, M. J. Mack, S. R. Hazelrigg, P. F. Ferson, R. J. Keenan, J. D. Luketich, A. P. Yim, and G. F. Coloni
Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases
Eur. J. Cardiothorac. Surg., December 1, 2000; 18(6): 671 - 677.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. Eichfeld, A. Tannapfel, M. Steinert, and T. Friedrich
Evaluation of ultracision in lung metastatic surgery
Ann. Thorac. Surg., October 1, 2000; 70(4): 1181 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. B. Zwischenberger and S. K. Alpard
Pulmonary metastasectomy
Ann. Thorac. Surg., July 1, 1999; 68(1): 287 - 288.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.